Thyroid Cancer Coverage from Every Angle

Recent News

Are Serum Thyroglobulin Levels a Reliable Marker of Recurrence in Thyroid Cancer?
Simultaneous Primary Hyperparathyroidism and Thyroid Carcinomas: Rare Case Study
ASTRO 2020: High-Dose Iodine-131 Ablation for High-Risk Thyroid Cancer
ASTRO 2020: Locoregional Failure Patterns With IMRT for Anaplastic Thyroid Cancer
ASTRO 2020: Does a Reduced Radiation Field Decrease Toxicity in Advanced Thyroid Cancer?
Lenvatinib in Advanced Anaplastic Thyroid Cancer: Real-World Setting
Differentiated Thyroid Cancer Korean Study Focuses on Unusual Metastases
Refining Outcome Prognostication After Initial Treatment of Differentiated Thyroid Cancer
ESMO 2020: Lenvatinib Plus Pembrolizumab in Metastatic Thyroid Carcinoma
ESMO 2020: Influence of Selpercatinib on Diarrhea in Patients With Medullary Thyroid Cancer
ESMO 2020: Multikinase Inhibitors for Asymptomatic Radioiodine-Refractory Thyroid Cancer
Papillary Thyroid Cancer: Rare Case of Anaplastic Transformation in Mesentery Metastases
ESMO 2020: Predicting Response to Radioiodine Treatment in Thyroid Cancer With Bone Metastasis
ESMO 2020: Nintedanib in Progressive Medullary Thyroid Cancer
Using Liquid Biopsy to Detect BRAF V600E in Papillary Thyroid Cancer
IGCS 2020: Thyroid Cancer and Pregnancy in Belarus
Rare Case of Lymph Node Metastasis of Papillary Thyroid Cancer to the Tongue
Radioactive Iodine Treatment After Thyroidectomy: Impact on Blood Cell Counts
Connection Between Lymph Node Ratio and Mortality Risk in Papillary Thyroid Cancer?
Combination Therapy for BRAF-Mutant Thyroid Cancer: Preclinical Model
Long-Term Salivary Toxicity From Radioiodine Treatment of Thyroid Cancer
Are Personalized Therapies Sparking Improvement in Survival in Anaplastic Thyroid Cancer?
Update on Worldwide Epidemiologic Trends in Thyroid Cancer
Do All Patients With Papillary Thyroid Cancer Require Radioiodine Therapy?
Targeting Certain Genes With Iodine-131 Radiotherapy for Thyroid Cancer
Viewer Makes ‘Accurate’ Diagnosis of Thyroid Cancer in Television Newscaster
Who May Benefit From Radioactive Iodine Ablation of Intermediate-Risk Papillary Thyroid Cancer?
COVID-19 and Thyroid Malignancies: Italian Researchers Focus on Quality of Life
Health-Related Quality of Life: RFA Versus Surgery for Papillary Thyroid Microcarcinoma
Management of Secondary Differentiated Thyroid Carcinoma in Childhood Cancer Survivors
Radiation Therapy Plus TKIs for Medullary Thyroid Cancer: Preclinical Study Findings
Does Anaplastic Thyroid Carcinoma Respond to PD-1 Blockade?
Does Body Weight Affect Thyroid Cancer Risk?
Relationship Between Thyroid Dysfunction and Risk of Thyroid and Breast Cancers
Understanding Resistance to Vandetanib in Medullary Thyroid Carcinoma
ASCO20: Update on RAS-Mutated Sporadic Medullary Thyroid Cancer
COVID-19 and Head/Neck Cancer: International Consensus on Surgical Practice
ASCO20: Can Radioiodine Plus Durvalumab Improve Outcomes in Resistant Thyroid Cancer?
ASCO20: Outcomes in Subgroups of Patients With Medullary Thyroid Carcinoma Treated With Anlotinib
Quality of Life After Thyroidectomy: Many Factors at Play
ASCO20: Treating Anaplastic Thyroid Cancer Based on Driver Mutations
ASCO20: Selpercatinib for RET-Mutant Medullary Thyroid Cancer
ASCO20: Combination Immunotherapy for Aggressive Thyroid Cancers
ENDO 2020: Did AJCC8 Criteria Improve Racial and Ethnic Outcomes Disparities in Thyroid Cancer?
ASCO20: Lenvatinib Plus Pembrolizumab in Radioiodine-Refractory Thyroid Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.